1106 Thiers Journal of the American Academy of Dermatology human epidermal cells. J Invest Dermatol 75: 185-186, 1980. 23. Diaz L, Calvanico N, Tomasi T Jr, et al: Bullous pemphigoid antigen: Isolation from normal human skin. J Immunol 199:455-460, 1977. 24. Diaz L, Patel H, Calvanico N: Bullous pemphigoid antigen. II. Isolation from the urine of a patient. J lmmunol 122:605-608, 1979. 25. Grekin P, Levy G, King A, et al: Some biochemical properties of pemphigoid antigen bound to the surface of dissociated epidermal cells. J Invest Dermatol 76:190- 192, 1981. 26. Dubertret L, Bertanx B, Fosse M, et al: Cellular events leading to blister formation in bullous pemphigoid. Br J Dermatol 104:615-624, 1980. 27. Czarnetzki B, Kalveram K, Dierksmeier U: Serum eosinophil chemotactic factor levels in patients with bullous pemphigoid, drug reactions and atopic eczema. J Invest Dermatol 73:163-165, 1979. 28. Baba T, Sonozaki H, Seki K, et al: An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients. J Immunol 116:112-116, 1976. 29. Wintroub R, Mihm M Jr, Goetzl E, et al: Morphologic and functional evidence for release of mast cell products in bullous pemphigoid, N Engl J Med 298:417-421, 1978. 30. Person J, Rogers R III: Bullous and cicatriciat pemphi- gold: Clinical, histopathologic and immunopathologic correlations. Mayo Clin Proc 52:54-66, 1977. 31. Hodge L, Marsden R, Black M, et al: Bullous pemphigoid: The frequency of mucosal involvement and concurrent malignancy related to indirect immunofluo- rescence findings. Br J Dermatol 105:65-69, 1982. 32. Angelopoulos A, Laskaris G: Cicatricial pemphigoid: Direct and indirect immunofluorescent studies. Oral Surg 51:48-54, 1981. 33. Dantzig P: Circulating antibodies in cicatricial pemphigoid. Arch Dermatol 108:264-266, 1973. 34. Rogers R, Perry H, Bean S, et al: Immunopathology of cicatricial pemphigoid: Studies of complement deposi- tion. J Invest Derrnatol 68:39-43, I977. CORRECTION In Thiers B: "Immunotherapy of malignant melanoma" (J AM ACAD DERMATOL 6:559-562, 1982), reference number 40 should read: Bart R, Kopf A: Inhibition of the growth of murine'malignant melanoma with synthetic double-stranded ribonucleic acid. Nature 224:372-373, 1969.

Correction

Download PDF Report

Upload
hanhi
View
217
Download
0

Embed Size (px)

Citation preview

1106 Thiers

Journal of the Amer ican Academy of

Dermatology

human epidermal cells. J Invest Dermatol 75: 185-186, 1980.

23. Diaz L, Calvanico N, Tomasi T Jr, et al: Bullous pemphigoid antigen: Isolation from normal human skin. J Immunol 199:455-460, 1977.

24. Diaz L, Patel H, Calvanico N: Bullous pemphigoid antigen. II. Isolation from the urine of a patient. J lmmunol 122:605-608, 1979.

25. Grekin P, Levy G, King A, et al: Some biochemical properties of pemphigoid antigen bound to the surface of dissociated epidermal cells. J Invest Dermatol 76:190- 192, 1981.

26. Dubertret L, Bertanx B, Fosse M, et al: Cellular events leading to blister formation in bullous pemphigoid. Br J Dermatol 104:615-624, 1980.

27. Czarnetzki B, Kalveram K, Dierksmeier U: Serum eosinophil chemotactic factor levels in patients with bullous pemphigoid, drug reactions and atopic eczema. J Invest Dermatol 73:163-165, 1979.

28. Baba T, Sonozaki H, Seki K, et al: An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients. J Immunol 116:112-116, 1976.

29. Wintroub R, Mihm M Jr, Goetzl E , et al: Morphologic and functional evidence for release o f mast cell products in bullous pemphigoid, N Engl J Med 298:417-421, 1978.

30. Person J, Rogers R III: Bullous and cicatriciat pemphi- gold: Clinical, histopathologic and immunopathologic correlations. Mayo Clin Proc 52:54-66, 1977.

31. Hodge L, Marsden R, Black M, et al: Bullous pemphigoid: The frequency of mucosal involvement and concurrent malignancy related to indirect immunofluo- rescence findings. Br J Dermatol 105:65-69, 1982.

32. Angelopoulos A, Laskaris G: Cicatr icial pemphigoid: Direct and indirect immunofluorescent studies. Oral Surg 51:48-54, 1981.

33. Dantzig P: Circulating antibodies in cicatricial pemphigoid. Arch Dermatol 108:264-266, 1973.

34. Rogers R, Perry H, Bean S, et al: Immunopathology of cicatricial pemphigoid: Studies of complement deposi- tion. J Invest Derrnatol 68:39-43, I977.

C O R R E C T I O N

In Thiers B: " Immunotherapy of malignant me lanoma" (J AM ACAD DERMATOL 6:559-562, 1982), reference number 40 should read: Bart R, Kopf A: Inhibition o f the growth of mur ine 'mal ignan t melanoma with synthetic double-stranded ribonucleic a c i d . Nature 224:372-373, 1969.